Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Herrmann

Showing results (841-850 of 853) with videos related to

Pageof 86
Sort By:
Journal of the American Medical Directors Association|November 3, 2020
Predictors of In-Hospital Mortality in Older Patients With COVID-19: The COVIDAge StudyAline Mendes, Christine Serratrice, François R Herrmann, et al.
Journal of the American Medical Directors Association|November 28, 2024
Clinical Predictors of Mortality in People with Severe Behavioral and Psychological Symptoms of DementiaAline Mendes, François R Herrmann, Sverre Bergh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1998
Mantle-cell lymphomas have more widespread disease and a slower response to chemotherapy compared with follicle-center lymphomas: results of a prospective comparative analysis of the German Low-Grade Lymphoma Study GroupW Hiddemann, M Unterhalt, R Herrmann, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1981
Comparison of ftorafur with 5-fluorouracil in combination chemotherapy of advanced gastrointestinal carcinomaW Queisser, G Schnitzler, J Schaefer, et al.
Leukemia|May 1, 1996
Prednimustine, mitoxantrone (PmM) vs cyclophosphamide, vincristine, prednisone (COP) for the treatment of advanced low-grade non-Hodgkin's lymphoma. German Low-Grade Lymphoma Study GroupM Unterhalt, R Herrmann, M Tiemann, et al.
Blood|March 1, 1996
A randomized study of high-dose cytarabine in induction in acute myeloid leukemiaJ F Bishop, J P Matthews, G A Young, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2015
Bevacizumab continuation versus no continuation after first-line chemotherapy plus bevacizumab in patients with metastatic colorectal cancer: a randomized phase III non-inferiority trial (SAKK 41/06)D Koeberle, D C Betticher, R von Moos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2001
Adenovirus-mediated wild-type p53 gene transfer in patients receiving chemotherapy for advanced non-small-cell lung cancer: results of a multicenter phase II studyM Schuler, R Herrmann, J L De Greve, et al.
Human Molecular Genetics|December 14, 2001
Mutations in the fukutin-related protein gene (FKRP) identify limb girdle muscular dystrophy 2I as a milder allelic variant of congenital muscular dystrophy MDC1CM Brockington, Y Yuva, P Prandini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 20, 2004
Interferon-alpha-2b and oral cytarabine ocfosfate for newly diagnosed chronic myeloid leukaemiaP Mollee, C Arthur, T Hughes, et al.
Pageof 86

Showing results (841-850 of 853) with videos related to

Sort By:
Pageof 86
Journal of the American Medical Directors Association|November 3, 2020
Predictors of In-Hospital Mortality in Older Patients With COVID-19: The COVIDAge StudyAline Mendes, Christine Serratrice, François R Herrmann, et al.
Journal of the American Medical Directors Association|November 28, 2024
Clinical Predictors of Mortality in People with Severe Behavioral and Psychological Symptoms of DementiaAline Mendes, François R Herrmann, Sverre Bergh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1998
Mantle-cell lymphomas have more widespread disease and a slower response to chemotherapy compared with follicle-center lymphomas: results of a prospective comparative analysis of the German Low-Grade Lymphoma Study GroupW Hiddemann, M Unterhalt, R Herrmann, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1981
Comparison of ftorafur with 5-fluorouracil in combination chemotherapy of advanced gastrointestinal carcinomaW Queisser, G Schnitzler, J Schaefer, et al.
Leukemia|May 1, 1996
Prednimustine, mitoxantrone (PmM) vs cyclophosphamide, vincristine, prednisone (COP) for the treatment of advanced low-grade non-Hodgkin's lymphoma. German Low-Grade Lymphoma Study GroupM Unterhalt, R Herrmann, M Tiemann, et al.
Blood|March 1, 1996
A randomized study of high-dose cytarabine in induction in acute myeloid leukemiaJ F Bishop, J P Matthews, G A Young, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2015
Bevacizumab continuation versus no continuation after first-line chemotherapy plus bevacizumab in patients with metastatic colorectal cancer: a randomized phase III non-inferiority trial (SAKK 41/06)D Koeberle, D C Betticher, R von Moos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2001
Adenovirus-mediated wild-type p53 gene transfer in patients receiving chemotherapy for advanced non-small-cell lung cancer: results of a multicenter phase II studyM Schuler, R Herrmann, J L De Greve, et al.
Human Molecular Genetics|December 14, 2001
Mutations in the fukutin-related protein gene (FKRP) identify limb girdle muscular dystrophy 2I as a milder allelic variant of congenital muscular dystrophy MDC1CM Brockington, Y Yuva, P Prandini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 20, 2004
Interferon-alpha-2b and oral cytarabine ocfosfate for newly diagnosed chronic myeloid leukaemiaP Mollee, C Arthur, T Hughes, et al.
Pageof 86